| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |